Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Martin

Showing results (41-50 of 312) with videos related to

Pageof 32
Sort By:
Neural Development|April 10, 2010
Pharmacological manipulation of GABA-driven activity in ovo disrupts the development of dendritic morphology but not the maturation of spinal cord network activityYone J Yoon, Alexander P Gokin, Miguel Martin-Caraballo
Sensors (Basel, Switzerland)|November 11, 2022
Real-Time Pipe and Valve Characterisation and Mapping for Autonomous Underwater Intervention TasksMiguel Martin-Abadal, Gabriel Oliver-Codina, Yolanda Gonzalez-Cid
American Journal of Physiology. Cell Physiology|December 24, 2010
Leukemia inhibitory factor regulates trafficking of T-type Ca2+ channelsDeblina Dey, Andrew Shepherd, Judith Pachuau, et al.
Journal of the National Cancer Institute|April 5, 2017
RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM TrialMiguel Martin, John Boyer, Mary Stuart, et al.
Scientific Data|February 10, 2026
MORICHI: a Dataset to Study Urban Overheating during Extreme Heat in a Hot-Summer Humid Continental ClimateMiguel Martin, Clara Garcia-Sanchez, Jantien Stoter, et al.
Oncology and Therapy|May 31, 2021
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast CancerMichael Untch, Miguel Martin, Michelino De Laurentiis, et al.
JAMA Oncology|September 29, 2022
Quantifying Clinical Utility of Adjuvant Abemaciclib in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy-ReplyRan Jennifer Wei, Miguel Martin, Stephen R D Johnston
Breast Care (Basel, Switzerland)|December 14, 2017
Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast CancerIsabel Echavarria, Yolanda Jerez, Miguel Martin, et al.
Bioorganic & Medicinal Chemistry|May 10, 2022
Evaluation of potential anticonvulsant fluorinated N-benzamide enaminones as T-type Ca<sup>2+</sup> channel blockersIsis J Amaye, Patrice L Jackson-Ayotunde, Miguel Martin-Caraballo
European Journal of Cancer (Oxford, England : 1990)|January 20, 2012
Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive reviewDavid Miles, Christoph Zielinski, Miguel Martin, et al.
Pageof 32

Showing results (41-50 of 312) with videos related to

Sort By:
Pageof 32
Neural Development|April 10, 2010
Pharmacological manipulation of GABA-driven activity in ovo disrupts the development of dendritic morphology but not the maturation of spinal cord network activityYone J Yoon, Alexander P Gokin, Miguel Martin-Caraballo
Sensors (Basel, Switzerland)|November 11, 2022
Real-Time Pipe and Valve Characterisation and Mapping for Autonomous Underwater Intervention TasksMiguel Martin-Abadal, Gabriel Oliver-Codina, Yolanda Gonzalez-Cid
American Journal of Physiology. Cell Physiology|December 24, 2010
Leukemia inhibitory factor regulates trafficking of T-type Ca2+ channelsDeblina Dey, Andrew Shepherd, Judith Pachuau, et al.
Journal of the National Cancer Institute|April 5, 2017
RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM TrialMiguel Martin, John Boyer, Mary Stuart, et al.
Scientific Data|February 10, 2026
MORICHI: a Dataset to Study Urban Overheating during Extreme Heat in a Hot-Summer Humid Continental ClimateMiguel Martin, Clara Garcia-Sanchez, Jantien Stoter, et al.
Oncology and Therapy|May 31, 2021
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast CancerMichael Untch, Miguel Martin, Michelino De Laurentiis, et al.
JAMA Oncology|September 29, 2022
Quantifying Clinical Utility of Adjuvant Abemaciclib in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy-ReplyRan Jennifer Wei, Miguel Martin, Stephen R D Johnston
Breast Care (Basel, Switzerland)|December 14, 2017
Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast CancerIsabel Echavarria, Yolanda Jerez, Miguel Martin, et al.
Bioorganic & Medicinal Chemistry|May 10, 2022
Evaluation of potential anticonvulsant fluorinated N-benzamide enaminones as T-type Ca<sup>2+</sup> channel blockersIsis J Amaye, Patrice L Jackson-Ayotunde, Miguel Martin-Caraballo
European Journal of Cancer (Oxford, England : 1990)|January 20, 2012
Combining capecitabine and bevacizumab in metastatic breast cancer: a comprehensive reviewDavid Miles, Christoph Zielinski, Miguel Martin, et al.
Pageof 32